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Overview of thymocytes development
Multipotential progenitor cells receive numerous
intracellular signals during the differentiation from
the interaction of the cell surface receptors with vari-
ous types of ligands (1). The biochemical changes
induced in the progenitor cells by these interactions
alter the expression and function of specific transcrip-
tion factors, which leads to either the production of
cell survival or cell death signals, which result in either
the development of a differentiated cell of a particu-
lar lineage or the elimination of that cell respectively.
Thymocyte development also proceeds through
an ordered series of proliferation and maturation events
that first generates immature T-cells with a pre-T cell
antigen receptor complex, followed by the develop-
ment of mature T-cells with a diverse repertoire of
antigen-specific αβ T-cell receptors encoded by so-
matically rearranged gene segments (2-4). αβ T-cell
development is controlled by signals that arise from
interactions between the clonally expressed antigen
receptor and ligands that consist of self-peptides bound
to major histocompatibility complex (MHC)molecules
expressed on thymic stromal cells. These signals either
lead to continued maturation (positive selection) or
to activation-induced cell death (negative selection)
(3, 5, 6). The fate of each developing T-cell is thus
believed to depend on the strength and timing of the
TCR-MHC interaction, in which weak interactions
promote positive selection and strong interactions
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lead to thymocyte activation and cell death (5, 6).
Models for CD 4/CD 8 T-cell lineage choice
These same TCR interactions with self-peptide and
MHC ligands also dictate the lineage fate of imma-
ture CD4+CD8+ (double positive or DP) thymocytes.
Studies have shown that the TCR specificity for either
class I or class II thymic MHC molecules ultimately
determines whether a T-cell develops into a mature
CD8+ cytotoxic T-cell or a CD4+ helper T-cell, respec-
tively (7-9). CD4, which is specific for MHC class
II, and CD8, which is specific for MHC class I, are
proteins that show peptide-independent, MHC-class
specific interactions. It was initially postulated that
the CD4/CD8 lineage choice occurred by an instruc-
tive mechanism, such that co-engagement of the
αβTCR and the CD8 coreceptor by MHC class I mol-
ecules or the αβTCR and CD4 coreceptor by MHC
class II molecules would result in qualitatively dis-
tinct signals directing differentiation into the CD8
or CD4 lineage, respectively (5).
Early TCR transgenic mice experiments were con-
sistent with this notion. However, subsequent studies
suggested that the match between coreceptor expres-
sion and the TCR MHC bias was ascribed to a two-step
process that involved an initial stochastic lineage
choice upon initial TCR signaling, which led to the
loss of either CD4 or CD8 expression. The next step
was to determine if the remaining coreceptor was
able to participate in ligand recognition with the TCR.
Cells with incompatible TCR and coreceptor combi-
nations would die due to a lack of appropriate sur-
vival signals at this second maturation step. This view
became known as the CD4/CD8 lineage development
stochastic/selection model (10-13).
Recent experiments suggested that the observa-
tions leading to the competing instructive and selec-
tive models could be accommodated by postulating
that quantitative differences in TCR and coreceptor
signaling were transformed into qualitative differ-
ences in cell behavior. Instruction did occur, but not
through a mechanism requiring unique biochemical
signals from co-engagement of the TCR with either
CD4 or CD8. Instead, stronger signals favor CD4
development, whereas weaker signals favor CD8 de-
velopment (14, 15). These proposals failed to address
how the signal “strength” leading to the proper lin-
eage choice could be predictably obtained by T-cells
expressing random specificities for MHC class I vs.
class II molecules and assumed that identical signals
controlled fate restriction and subsequent matura-
tion.
Duration of TCR signaling and CD4/CD8
T-cell fate choice
Our analysis led us to conclude that a major prob-
lem in understanding thymocyte developmental regu-
lation was the inability to accurately control the na-
ture, quantity, and quality of TCR-ligand interactions.
Further progress required a model that permitted
the manipulation of these parameters, while at the
same time, preserved the utilization of physiologi-
cal ligands and the complex thymic organization. To
this end, we have developed a modified version of
the reaggregate culture method of Jenkinson and
Owens that permits experimental variation in the TCR
ligands at early versus late differentiation stages. This
system also allows modification of the proteins ex-
pressed by the T-cells or the surrounding stromal
cells in a quasi-physiological organ culture environ-
ment (Fig. 1) (16). The modified two-step reaggregate
culture system uses thymocytes expressing AND
(MHC class II specific) or HY (MHC class I specific)
TCR together with presenting cells with wild-type or
mutant MHC loci and various inhibitors, which in-
clude antibodies and antisense RNAs. Specifically,
CD4+CD8+ thymocytes from TCR transgenic mice
were crossed with RAG-2-/- mice. On a non-selective
background, the CD4+CD8+ thymocytes were stimu-
lated by splenic or thymic dendritic cells (DC) in
the presence or absence of specific antigenic peptides
for 20 hours (1st step). CD69hi cells were purified
and reaggregated with thymic stromal cells (TSC)
plus DC and cultured for several days (2nd step). The
TCR signal at the1st step does not turn off CD4 or
CD8 gene expression, which is assessed by a pronase
stripping and re-expression assay. Instead, selective
CD4 or CD8 expression is seen on most cells emerging
from the second culture step. Using this system, it
became possible to manipulate the TCR and other
extrinsic signals in each thymocyte differentiation
step. We have recently reported that bipotentiality
loss by DP thymocytes (lineage commitment) occurs
rapidly upon TCR and coreceptor engagement, with
the CD4 vs. CD8 choice showing a clear dependence
on the duration of effective TCR signaling. A short
signal (4 hr) promotes CD8 development, whereas
with the same T-cell population and ligand, prolonged
signaling (14 hr) leads to CD4 development. Inter-
estingly, although the signaled cells show loss of
bipotentiality within this time frame, they do not show
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selective silencing of CD4 or CD8 expression if main-
tained in a culture lacking stromal cells. Thus, lineage
commitment can be clearly separated from signals
necessary for lineage progression among commit-
ted cells. In a second stage culture of committed cells
with thymic stroma, phenotypic change and func-
tional maturation does occur (Fig. 2).
These data add substantially to our understanding
of thymocyte development in terms of the extrinsic
signals controlling lineage specific differentiation ;
however, they do not address the more fundamental
questions of (i) how in a relatively predictable man-
ner MHC class I vs. class II ligands lead to short vs.
long duration signals in most precursor T-cells ; (ii)
how TCR signaling differences restrict development
potential at the molecular level ; or (iii) how TCR and
other signals are integrated to control the lineage
specific genetic program that results in CD4 vs. CD8
Fig. 1 Scheme of experimental system for examining molecular basis of CD4/CD8 lineage choice
Outline of T-cell development. This figure shows a model of CD4/CD8 T-cell lineage choice.
Fig. 2 Scheme of T-cell development
Experimental system for examining the molecular basis of CD4/CD8 lineage choice. This figure shows a two-stage thymocyte culture
system. CD4+CD8+ cells from TCR transgenic mice crossed with rag2 -/- (neutral background) are stimulated with a given antigen
for 20 hours in suspension culture. The sorted live CD69+ cells are cultured with thymic stromal cells in the thymocyte reaggregate
culture system for 3-4 days. The phenotype or thymocyte cell number are evaluated by flow cytometry.
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mature T-cells. Regarding the first issue, it is clear
that the same a and b gene segments are used to cre-
ate the receptors that show preferential binding to
self-peptides presented by MHC class I vs. MHC
class II molecules. Also, biophysical measurements
have failed to detect a systematic difference in ligand
binding affinity of MHC class I vs. class II specific
TCR. Interestingly, the class I and class II ligand abun-
dance is similar on thymic stromal cells. Therefore,
it is difficult to imagine that there is a predictable
bias in the TCR affinity interacting with MHC class
I vs. MHC class II ligands in the thymus, or even a
difference in the available ligand quantity to these
TCR. Thus, the distinct duration of the signal origin
in response to MHC class I vs. class II ligands is likely
to arise from a different source. There is strong evi-
dence that the association of the src family kinase
Lck with CD4 is strikingly different from its associa-
tion with CD8, with the former being much more
extensive in DP thymocytes. Based on previous
work, the nature of TCR induced proximal tyrosine
phosphorylation events is regulated by the extent of
co-recruitment of Lck-coupled coreceptors (17). The
Lck-deficiency of most CD8 molecules on DP thymocytes
would thus favor limited signaling in comparison to
CD4 with its high ratio of Lck. Placing the critical
distinction between class I vs. class II recognition on
the coreceptor acting in concert with the TCR sup-
ports the data on the ability of a coreceptor cytoplas-
mic tail switch to markedly change cell fate, because
this is the region of the molecule regulating Lck as-
sociation. It is also possible that alternation in proximal
tyrosine phosphorylation seenwhenTCR are deprived
of effective coreceptor binding is associated with a
more rapid desensitization of the receptor pool by
phosphatases. This is consistent with the evidence
mentioned above that signaling duration is key in the
fate decision process.
What molecular events result from long vs. short
duration TCR signals and constrain developmental po-
tential (mediate linage commitment) remain unknown.
One candidate for controlling the CD4 vs. CD8 de-
cision is MAPK. Interference with MAPK activity
limits CD4 but not CD8 development, whereas in-
creased MAPK activity results in CD4 development
(18). Recent studies have revealed that ERK directly
modifies Lck and changes its susceptibility to SHP-1
binding and inactivation (17). This positive feedback
loop plays a dominant role in controlling the effective
TCR signaling duration. Thus, existing data on MAPK
can also be interpreted as a regulator of proximal TCR
signaling. This leaves the entire spectrum of down-
stream signaling pathways open in terms of their role
and relevance to the commitment and progression events.
Thus, it will be important to examine both protein
modifications and gene expression changes that occur
differentially in CD4 vs. CD8 committed thymocytes
to determine how TCR signaling differences are con-
verted into developmental potential limitations and
the CD4 or CD8 maturation program.
Notch and CD4/CD8 lineage commitment
In addition to TCR signaling, the general cell differ-
entiation regulator Notch has been examined for its
role in this fate decision. Robey et al. first proposed
that Notch activity plays a critical role in lineage com-
mitment toward CD8, based on results using mice
expressing a truncated, active Notch-1 transgene (19).
However, Deftos et al. have reported that Notch ex-
pression prolongs cell survival by upregulating Bcl-2.
They concluded that the increased cell survival of
CD4+CD8+ thymocytes in Notch-1 transgenic mice
could result in an apparent bias towards CD8+CD4-
T-cells, based on a similar phenotype in Bcl-2 transgenic
mice (20). Neither of these experimental systems has
examined separately the role of Notch in both early
and late phases of thymocyte selection and differentia-
tion. Based on our evidence for separation between
the commitment and progression phases of T cell dif-
ferentiation, we utilized our two-step culture system
to examine the effects of a Notch blocking antibody
or expression of a retrovirus encoding anti-sense
Notch-1. With both, we found that interfering withNotch
activity affects CD8+ but not CD4+ T-cell development
(16). The results using the anti-Notch-1 mAb showed
that inhibition of Notch activity blocks the CD8+ T-cell
development, but does not enhance CD4+ T-cell de-
velopment. These results suggest that Notch activity
contributes only to cell lineage progression commit-
ted to the CD8 pathway and not the actual lineage
decision process.
Subsequent reports by Wolfer et al. showed that
Notch-1 conditional inactivated mice do not have any
defect in CD4 and CD8 T-cell development, arguing
that Notch-1 does not contribute to the lineage de-
cision between CD4 and CD8 T-cells (21, 22). Rather,
Notch-1 is involved in the lineage fate choice between
T-cells and B-cells (22). Our results are obtained from
the analysis of fetal thymocytes. Previous reports
indicated there is a clear difference in Notch recep-
tor expression patterns in fetal and adult thymocytes
(23). Thus, the discrepancy may be due to the cell
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origin. Another possibility is that other Notch recep-
tors contribute to the lineage fate choice between
CD4 and CD8 T-cells. Those issues should be clarified
by additional Notch gene inactivation studies and the
subsequent analysis of the mature T-cells from those
studies.
Conclusion remarks
There are many types of transgenic mice available
to evaluate the role of numerous genes in thymocyte
development, including CD4/CD8 lineage choice.
However, such studies generally do not clarify if the
genes regulate lineage commitment, cell survival, or
cell differentiation. In order to examine precisely the
role of these genes, our two-step thymocyte culture
system may be useful to answer these and other ques-
tions.
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